HLIO vs IONS · P/E 47, rev $460.3M vs rev $514.0M
Helios Technologies Inc (HLIO) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Helios Technologies Inc (HLIO) is a specialty industrial machinery company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported HLIO revenue for 2026-07-04 was $460.3M. Net income was $41.6M. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
HLIO currently screens at market cap $2.84B and trailing P/E 47.2. IONS currently screens at market cap $12.28B.
Not investment advice. Open the HLIO and IONS stock pages for the full models.
Not investment advice.